Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Japan's Asahi Kasei, through it...
South Korea-based SK bioscience has announced that together with IDT Biologika (IDT) and Australian biotechnology compan...
US-based Sarepta Therapeutics, Inc. has announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Ja...
US-based Bruker Corporation has announced new advancements to enable Functional Proteomics 2.0 workf...
Japan-based Astellas Pharma and US-based startup Vir Biotechnology have entered into a global strategic collaboration to...
Taiwan-headquartered Bora Pharmaceuticals, a global leader in pharmaceutical manufacturing, and British pharma firm...
Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals...
ImmunityBio, Inc., a commercial-stage immunotherapy company based in the US, has announced a partnership with Biopharma ...
US-based Catalent and South Korea-based S.Biomedics have announced a strategic partnership to support the development an...
Johnson & Johnson has announced more than $1 billion investment in a next generation cell therapy manufacturing faci...
US-based Waters Corporation has launched 1 mm I.D. liquid chromatography (LC) columns with Waters' MaxPeak&tra...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Galux, a South Korea-based biotech startup pioneering artificial intelligence (AI)-driven protein therapeutics design, h...
QuidelOrtho has entered a long-term strategic supply agreement with China's Lifotronic Technology, to expand QuidelOrtho...
Japan-headquartered Nxera Pharma has entered into a license agreement with a newly established independent company (NewC...
CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that through its in...
PharmaEssentia Corporation, a global biopharmaceutical company headquartered in Taiwan with deep expertise in the develo...
Galderma has announced the launch of Restylane Defyne and Restylane Refyne: the first Optimal Balance Technology (OBT)â...
India's OneSource Specialty Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Oze...
Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...
Germany-based medisana, a trusted global brand in home health and wellness solutions, has announced a strategic partners...
South Korea-based GCCL Co., a data-driven clinical trial services provider, and Germany-based Medicover Integrated Clini...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Singapore-headquartered Zuellig Pharma has acquired all rights, title, and interest in and to the Zam-Buk® and Vapex...
